Cargando…

Application of the BacT/ALERT(R) 3D system for sterility testing of injectable products

Sterility testing as described in the pharmacopoeia compendia requires a 14-day incubation period to obtain an analytical result. Alternative methods that could be applied to evaluating product sterility are especially interesting due to the possibility of reducing this incubation period and thus th...

Descripción completa

Detalles Bibliográficos
Autores principales: Bugno, Adriana, Lira, Rodolfo Santos, Oliveira, Wesley Anderson, Almodovar, Adriana Aparecida Buzzo, Saes, Deborah Pita Sanches, de Jesus Andreoli Pinto, Terezinha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Microbiologia 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568852/
https://www.ncbi.nlm.nih.gov/pubmed/26413055
http://dx.doi.org/10.1590/S1517-838246320140587
Descripción
Sumario:Sterility testing as described in the pharmacopoeia compendia requires a 14-day incubation period to obtain an analytical result. Alternative methods that could be applied to evaluating product sterility are especially interesting due to the possibility of reducing this incubation period and thus the associated costs. The aims of this study were to evaluate the performance of the BacT/ALERT(R) 3D system in detecting microorganisms in large-volume parenteral solutions that were intentionally contaminated and to compare this system to pharmacopoeia sterility testing using the membrane filtration method. The results indicated that there were no significant differences between the methods regarding the ability to detect microbial contamination; however, detection with the BacT/ALERT(R) 3D system was faster compared to the pharmacopoeia method. Therefore, the BacT/ALERT(R) 3D system is a viable alternative for assessing the sterility of injectable products.